SPD BANK(SH:600000) Zhong Guo Jin Rong Xin Xi Wang·2025-07-08 01:36Core Viewpoint - The event "Medicine Without Boundaries, Innovation Sailing" hosted by Shanghai Pudong Development Bank focuses on the integration of artificial intelligence (AI) and the pharmaceutical industry, highlighting the rapid expansion of the healthcare market driven by various favorable factors such as aging population, policy support, and technological breakthroughs [1][3]. Group 1: Industry Insights - The aging population is continuously driving market demand, and the healthcare industry is experiencing rapid growth due to a combination of policy support, a recovering capital market, and AI-driven technological advancements [3]. - Experts from academia and industry discussed topics such as AI empowerment in biomedicine, new drug development strategies for neurological diseases, and brain-computer interfaces, emphasizing that medical AI is revolutionizing the modern healthcare ecosystem [3][4]. - The event aims to create a high-end platform for deep dialogue and collaborative innovation between government departments, investment institutions, research institutes, and biopharmaceutical companies, facilitating precise connections between capital and practice [4]. Group 2: Financial and Investment Aspects - Shanghai Pudong Development Bank shared a comprehensive service model for the entire lifecycle of biomedicine and provided key insights into the policy benefits and unique advantages for biopharmaceutical companies seeking to list in Hong Kong [4]. - Investment logic in the healthcare sector under the "AI + aging" context was elaborated by investment representatives, indicating a favorable environment for medical investments [4]. - The bank aims to build a comprehensive service system for technology enterprises and enhance collaborative innovation, positioning itself as a preferred banking partner for technology companies in the pharmaceutical sector [4].